Controlled Release Delivery System for Bio-Active Agents
First Claim
1. A controlled release delivery system comprising a bio-active compound and a matrix carrier, wherein said matrix carrier is an amorphous microporous non-fibrous silicon or titanium oxide being loaded with said bio-active compound and wherein the micropores of said matrix carrier have a mean size in the range of 0.4 to 2.0 nm.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides a controlled release delivery system comprising a bio-active compound and a matrix carrier, wherein said matrix carrier is an amorphous microporous non-fibrous silicon or titanium oxide being loaded with said bio-active compound and wherein the micropores of said matrix carrier have a mean size in the range of 0.4 to 2.0 nm.
-
Citations
47 Claims
- 1. A controlled release delivery system comprising a bio-active compound and a matrix carrier, wherein said matrix carrier is an amorphous microporous non-fibrous silicon or titanium oxide being loaded with said bio-active compound and wherein the micropores of said matrix carrier have a mean size in the range of 0.4 to 2.0 nm.
-
2-26. -26. (canceled)
- 43. A method of administration of at least one bio-active agent to a mammal, comprising the administration of a controlled release delivery system comprising said bio-active agent and a matrix carrier, wherein said matrix carrier is an amorphous microporous non-fibrous silicon or titanium oxide being loaded with said bio-active agent and wherein the micropores of said matrix carrier have a mean size in the range of 0.4 to 2.0 nm.
Specification